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Objective: To summarize literature on the concurrent and predictive validity of MRI-based measures of
osteoarthritis (OA) structural change.
Methods: An online literature search was conducted of the OVID, EMBASE, CINAHL, PsychInfo and
Cochrane databases of articles published up to the time of the search, April 2009. 1338 abstracts obtained
with this search were preliminarily screened for relevance by two reviewers. Of these, 243 were selected
for data extraction for this analysis on validity as well as separate reviews on discriminate validity and
diagnostic performance. Of these 142 manuscripts included data pertinent to concurrent validity and 61
manuscripts for the predictive validity review. For this analysis we extracted data on criterion
(concurrent and predictive) validity from both longitudinal and cross-sectional studies for all synovial
joint tissues as it relates to MRI measurement in OA.
Results: Concurrent validity of MRI in OA has been examined compared to symptoms, radiography,
histology/pathology, arthroscopy, CT, and alignment. The relation of bone marrow lesions, synovitis and
effusion to pain was moderate to strong. There was a weak or no relation of cartilage morphology or
meniscal tears to pain. The relation of cartilage morphology to radiographic OA and radiographic joint
space was inconsistent. There was a higher frequency of meniscal tears, synovitis and other features in
persons with radiographic OA. The relation of cartilage to other constructs including histology and
arthroscopy was stronger. Predictive validity of MRI in OA has been examined for ability to predict total
knee replacement (TKR), change in symptoms, radiographic progression as well as MRI progression.
Quantitative cartilage volume change and presence of cartilage defects or bone marrow lesions are
potential predictors of TKR.
Conclusion: MRI has inherent strengths and unique advantages in its ability to visualize multiple indi-
vidual tissue pathologies relating to pain and also predict clinical outcome. The complex disease of OA
which involves an array of tissue abnormalities is best imaged using this imaging tool.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Magnetic Resonance Imaging (MRI) is being developed as
amethod to assess jointmorphology in osteoarthritis (OA), with the: David J. Hunter, Rheuma-
d Northern Clinical School,
61-2-9926-7379; Fax: 61-2-
Hunter).
s Research Society International. Pgoal of providing a sensitive non-invasive tool for the study of
healthy and diseased states, and a means of assessing the effec-
tiveness of interventions for osteoarthritis. Traditionally structural
assessment of OA has relied upon the plain radiograph which has
capacity to image the joint space and osteophytes1. MRI has many
advantages in visualizing the joint, and recent efforts are yielding
a variety of approaches that offer the potential for monitoring this
prevalent synovial joint disease2. Because OA is a disease of the
whole synovial joint, not just the cartilage, measurements of
structure need to be seen broadly and capture important anatomic
features, including osteophytes, effusions, meniscal tears,ublished by Elsevier Ltd. All rights reserved.
1330 articles identified in 
OVID, PubMed and EMBASE 
8 articles identified manually 
1338 articles identified in total 
243 articles screened 
142 articles reporting 
concurrent validity results 
61 articles reporting predictive 
validity results 
Fig. 1. Flow chart of the screening process for articles included in the systematic
review.
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in addition to cartilage loss2. There is an abundant literature
describing the concurrent validity of MRI as it relates to comparable
constructs such as histology and radiography but little if any effort
has been made to systematically summarize this literature.
Similarly the merits of any OA structural assessment will
undoubtedly be assessed for their clinical relevance. There are
multiple determinants of pain and functional limitation in OA and
there may be many more unknown3. Many studies have examined
whether the loss of structural integrity is in some way the physical
correlate of these symptoms. Traditionally most epidemiologic
studies have relied upon plain radiography to deﬁne disease. The
major limitation of this method is that measures of symptoms
correlate poorly with x-ray features. Less than 50% of people with
evidence of OA on plain radiographs have symptoms related to
these ﬁndings4. Uncertainty as to whether measurements of MRI
structure alone will adequately reﬂect what structure connotes, or
whether other metrics of structure should also be considered, need
to be systematically evaluated. The relationships between structure
and pain and/or function and between structure and future
outcomes (e.g., arthroplasty) are critical in determining the clinical
relevance of MRI.
In psychometrics, validity refers to the degree to which a study
accurately reﬂects or assesses the speciﬁc concept that the
researcher is attempting to measure. There are many types of val-
idity of which one, criterion validity, is used to demonstrate the
accuracy of a measure or procedure by comparing it with another
measure or procedure which has been demonstrated to be valid.
There is a contention in theOAﬁeld about the validity of a number of
biomarkers and clinical endpoints and their inclusion here is in an
effort to be comprehensive and does not diminish the credible
concerns about the lack of well validated clinical endpoints5. If the
test data and criterion data are collected at the same time, this is
referred to as concurrent validity evidence. If the test data is
collected ﬁrst in order to predict criterion data collected at a later
point in time, then this is referred to as predictive validity evidence.
The purpose of this systematic reviewwas to summarize theOAMRI
literature with regards to both concurrent and predictive validity.
Material and methods
Systematic literature search details
An online literature search was conducted using the OVID
MEDLINE (1945e), EMBASE (1980e) and Cochrane databases
(1998e) to identify the articles published up to April 2009, with the
search entries “MRI”, and “osteoarthritis”, “osteoarthritides”,
“osteoarthrosis”, “osteoarthroses”, “degenerative arthritis”, “de-
generative arthritides”, or “osteoarthritis deformans”. The abstracts
of the 1330 citations received with this search were then prelimi-
narily screened for relevance by two reviewers (KH and DJH). For
this preliminary search, all articles which used MRI, in some form,
on patients with osteoarthritis of the knee, hip, or hand were
included. Although review articles were not included (see
Inclusion/exclusion criteria), citations found in any review articles
which were not already included in our preliminary search were
screened for possible inclusion in this study. This added 7 more
relevant studies to our search. One further article was added, before
publication, by one of authors of this meta-analysis bringing the
preliminary total to 1338.
Inclusion/exclusion criteria
Only studies published in English were included. Studies pre-
senting non-original data were excluded, such as reviews,editorials, opinion papers, or letters to the editor. Studies with
questionable clinical relevance and those using non-human
subjects or specimens were excluded. Studies inwhich rheumatoid,
inﬂammatory, or other forms of arthritis were included in the OA
datasets were excluded, as well as general joint-pertinent MRI
studies not focused on OA. Studies with no extractable, numerical
datawere excluded. Only those articles which had somemeasure of
diagnostic performance were included. Any duplicates which came
up in the preliminary search were excluded. Of the preliminary
1338 abstracts, 243 were selected for data extraction (Fig. 1).Data abstraction
Two reviewers (KH and LM) independently abstracted the
following data: (1) patient demographics; (2) MRI make,
sequences and techniques used, tissue types viewed; (3) study
type and funding source; (4) details on rigor of study design to
construct the Downs methodological quality score6; (5) MRI reli-
ability/reproducibility data; (6) MRI diagnostic measures and
performance; (7) gold standard measures against which the MRI
measure was evaluated; (8) treatment and MRI measures (when
appropriate).
The Downs methodological quality score6 collects a proﬁle of
scores for both randomized trials and observational studies in
terms of quality of reporting, internal validity (bias and con-
founding), power, external validity so that the overall study quality
score reﬂects all of these elements. Answers were scored 0 (No) or 1
(Yes), except for one item in the Reporting subscale, which scored
0e2 and the single item on power, which was scored 0e5. The
possible range is from 0 to 27 where 0 represents poor quality and
27 optimal quality.
We used a data abstraction tool constructed in EpiData (Entry
version 2.0 Odense, Denmark) and more than one reviewer
undertook the data abstraction. The data collection forms were
designed to target the objectives of the review, and were piloted
prior to conducting the study.
The outcomes for psychometric properties on MRI were exam-
ined using the OMERACT ﬁlter7,8. The speciﬁc focus of this review is
upon the truth domain: is the measure truthful, does it measure
what it intends tomeasure?More speciﬁcally wewere interested in
criterion validity; for both the concurrent [Does it agree (by inde-
pendent and blind comparison) with a measure that reﬂects the
same concept] and predictive [Does it predict (by independent and
blind comparison) a future ‘gold standard’] validity of MRI in OA. If
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is referred to as concurrent validity evidence. If the test data is
collected ﬁrst in order to predict criterion data collected at a later
point in time, then this is referred to as predictive validity evidence.
It is critical to delineate what we mean by the various terms
used, as current usage is often incorrect, and this ambiguity may
stem from an incorrect understanding of appropriate deﬁnitions.
Whilst there are several deﬁnitions that have been proposed9e13,
the brief synthesis of some working deﬁnitions is as follows:
1. biological marker (biomarker)d a characteristic that is objec-
tively measured and evaluated as an indicator of normal bio-
logical processes, pathogenic processes or pharmacologic
responses to a therapeutic agent.
2. clinical endpointda clinically meaningful measure of how
a patient feels, functions, or survives.
For the purposes of this analysis, MRI (the biomarker) is directly
compared both to clinical endpoints (symptoms, total knee
replacement (TKR)) as well as other biomarkers (including radi-
ography, CT, histology, arthroscopy, alignment). The presentation of
the data in the results reﬂects presentation of clinical endpoints
before comparison with other biomarkers.
There is some overlap in the manuscripts for which data is
extracted for these two types of validity. The large majority of
studies for concurrent validity were cross-sectional studies
although some longitudinal studies reported cross-sectional results
and thus are included in the concurrent validity data. There is no
attempt made to create summary estimates as the validity effect
measures [i.e., odds ratio (OR), Beta coefﬁcient, r, P-value of
difference] used in this literature are very heterogeneous.
Results
Concurrent validity (Table I)
The analysis included data from 142 manuscripts. The mean
Downs criteria score for these manuscripts was 8.3 (range 3e17).
What follows below are important excerpts from this data per-
taining to different aspects of concurrent validity. The data is
further summarized in Table II to discretely identify the associa-
tions examined and those where a signiﬁcant association was
found.
Relation to symptoms
21 studies examined the concurrent relation of MRI ﬁndings in
OA to symptoms. Of these, 62% demonstrated a statistically signif-
icant association, deﬁned as P< 0.05. Bone marrow lesions were
found in 272 of 351 (77.5%) persons with painful knees compared
with 15 of 50 (30%) persons with no knee pain (P< 0.001). Large
lesions were present almost exclusively in persons with knee pain
(35.9% vs 2%; P< 0.001). After adjustment for severity of radio-
graphic disease, effusion, age, and sex, lesions and large lesions
remained associated with the occurrence of knee pain [odds ratio,
3.31 (95% conﬁdence interval (CI), 1.54e7.41)]. Using the same
analytical approach, large lesions were also strongly associated
with the presence of pain [odds ratio, 5.78 (CI, 1.04e111.11)]. Among
persons with knee pain, bone marrow lesions were not associated
with pain severity14.
 After adjusting for the severity of radiographic OA, there was
a difference between those with and without knee pain in
prevalence of moderate or larger effusions (P< 0.001) and
synovial thickening, independent of effusion (P< 0.001).
Among those with small (grade 1) or no knee (grade 0)effusion, those with knee pain had a prevalence of synovial
thickening of 73.6% compared to 21.4% of those without knee
pain (P< 0.001). There was a signiﬁcant difference in visual
analogue scale (VAS) pain scores in those with synovial thick-
ening compared to those without synovial thickening, after
adjustment for radiographic severity, size of effusion, age, sex,
and BMI. The mean pain score in those with synovial thick-
ening after adjustment for radiographic severity and size of
effusion was 47.2 mm [standard error (SE) 6.0], compared to
28.2 mm (SE 2.8) in those without synovial thickening
(P¼ 0.006)15.
 Amedial or lateral meniscal tear was a very common ﬁnding in
the asymptomatic subjects (prevalence, 76%) but was more
common in the patients with symptomatic osteoarthritis (91%)
(P< 0.005). There was no signiﬁcant difference with regard to
the pain orWOMAC score between the patients with and those
without a medial or lateral meniscal tear in the osteoarthritic
group (P¼ 0.8 to 0.9 for all comparisons)16.
 Signiﬁcant differences between WOMAC scores were found for
the grades of cartilage lesions (P< 0.05) but not bone marrow
edema pattern, and ligamentous and meniscal lesions17.
 Bone marrow lesions >1 cm were more frequent (OR¼ 5.0;
95% CI¼ 1.4, 10.5) in the painful knee OA group than all other
groups. While the frequency of BME lesions was similar in the
painless OA and painful OA groups, there were more lesions,
>1 cm, in the painful OA group. Full-thickness cartilage defects
occurred frequently in painful OA. Women with radiographic
OA, full-thickness articular cartilage defects, and adjacent
subchondral cortical bone defects were signiﬁcantly more
likely to have painful knee OA than other groups (OR¼ 3.2; 95%
CI¼ 1.3, 7.6)18.
 Peripatellar lesions (prepatellar or superﬁcial infrapatellar)
were present in 12.1% of the patients with knee pain and ROA,
in 20.5% of the patients with ROA and no knee pain, and in 0% of
subjects with neither ROA nor knee pain (P¼ 0.116). However,
other periarticular lesions (including bursitis and iliotibial
band syndrome) were present in 14.9% of patients with both
ROA and knee pain, in only 3.9% of patients with ROA but no
knee pain, and in 0% of the groupwith no knee pain and no ROA
(P¼ 0.004)19.
 More severe symptoms relating to knee OA (pain, stiffness, and
function) are weakly inversely related to tibial cartilage
volume. Patients with lower cartilage volume had more severe
symptoms of knee OA than those with higher cartilage
volume20.
 The increase in median pain from median quantile regression,
adjusting for age and BMI, was signiﬁcant for bone attrition
(1.91, 95% CI 0.68, 3.13), bone marrow lesions (3.72, 95% CI 1.76,
5.68), meniscal tears (1.99, 95% CI 0.60, 3.38), and grade 2 or 3
synovitis/effusion vs grade 0 (9.82, 95% CI 0.38, 19.27). The
relationship with pain severity was of borderline signiﬁcance
for osteophytes and cartilage morphology and was not signif-
icant for bone cysts or meniscal subluxation. When compared
to the pain severity in knees with high scores for both bone
attrition and bone marrow lesions (median pain severity
40 mm), knees with high attrition alone (30 mm) were not
signiﬁcantly different, but knees with high bone marrow lesion
without high attrition scores (15 mm) were signiﬁcantly less
painful21.
 A large joint effusion was associated with pain (OR, 9.99; 99%
CI: 1.28, 149) and stiffness (OR, 4.67; 99% CI: 1.26, 26.1). The
presence of an osteophyte in the patellofemoral compartment
(OR, 2.25; 99% CI: 1.06, 4.77) was associated with pain. All other
imaging ﬁndings, including focal or diffuse cartilaginous
abnormalities, subchondral cysts, bone marrow edema,
Table I
Summary table of studies reporting data on concurrent validity of MRI in OA
Reference:
Author, Journal,
Year, PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs,
mean(SD),
range
No.
(%) of
females
Quantitative
cartilage
Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Score of
methodo
logical
quality
Chan WP;
American
Journal of
Roentgenology;
1991; 189204036
20 20 0 58(Range:
42e73)
11 No No Yes Yes No No No Yes Yes Cross-
sectional
6
McAlindon TE;
Annals of the
Rheumatic
Diseases; 1991;
199486190
12 No No Yes Yes Yes Yes No Yes No Case
control
3
Li KC; Magnetic
Resonance
Imaging; 1988;
339872891
10 10 0 (Range: 33e78) 9(90%) No No Yes Yes No No No No No Longitudinal
Prospective
4
Fernandez-Madrid
F; Magnetic
Resonance
Imaging; 1994;
793465692
92 52 40 Controls: 49(15),
(Rang: 22e78); OA
patients: 55(14),
(Range: 25e86)
60 No No Yes Yes Yes No No Yes No Cross-
sectional
11
Karvonen RL;
Journal of
Rheumatology;
1994; 796607527
92 52 40 Reference: 49(15),
(Range: 22e78);
All OA patients:
55(14), (Range: 25
e86); Bilateral OA:
53(13),
(Range: 25e73)
60 Yes No No Yes No Yes No No No Case control 11
Peterfy CG;
Radiology; 1994;
802942093
8 5 3 62(Range:
45e82)
4(50%) Yes No No Yes No No No No No Cross-
sectional
4
Blackburn WD Jr;
Journal of
Rheumatology;
1994; 803539237
33 33 0 62.7(9.1),
(Range: 44e79)
17 No No Yes Yes No No No No No Cross-
sectional
6
Broderick LS;
American
Journal of
Roentgenology;
1994; 827370061
23 13 10 No No Yes Yes No No No No No Cross-
sectional
4
Miller TT;
Radiology; 1996;
881655294
384 47(Range: 14e88) No No Yes Yes No No No Yes Yes Cross-
sectional
8
Dupuy DE;
Academic
Radiology; 1996;
895918157
7 TKA patients:
(Range: 64e75);
Asymptomatic:
35(Range: 25e35)
3 Yes No No Yes No No No No No Other 6
Kenny C; Clinical
Orthopaedics &
Related
Research; 1997;
918621595
136 No No Yes No No No No Yes No Case
control
6
Breitenseher MJ;
Acta Radiologica;
1997; 933224896
60 12 48 37(14.3), (Range: 15
e68)
30(50%) No No Yes No No No No Yes No Cross-
sectional
5
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Ostergaard M;
British Journal of
Rheumatology;
1997; 940286097
46 14 47 70(Range: 24e85) No No No No Yes No No No No Cross-
sectional
7
Trattnig S; Journal
of Computer
Assisted
Tomography;
1998; 944875498
20 20 0 72.2(Range: 62e82) 18 No No Yes Yes No No No No No Other 8
Kawahara Y; Acta
Radiologica;
1998; 952944062
72 58(Range: 41e74) 46 No No Yes Yes No No No No No Other 6
Drape JL;
Radiology; 1998;
964679263
43 43 0 63(Range: 53e78) 30 No No Yes Yes No No No No No Cross-
sectional
5
Eckstein F; Clinical
Orthopaedics &
Related
Research; 1998;
967804256
8 0 8 50.6(Range: 39e64) Yes No No Yes No No No No No Other 7
Uhl M; European
Radiology; 1998;
972442358
22 (Range: 50e72) No No Yes Yes No No No No No Cross-
sectional
5
Boegard T; Acta
Radiologica -
Supplementum;
1998; 975912199
61 No No Yes Yes No No No Yes No Longitudinal
Prospective
5
Bachmann GF;
European
Radiology; 1999;
993339964
320 29.3(8.7), (Range: 13
e56)
122 No No Yes Yes No No No Yes No Cross-
sectional
7
Cicuttini F;
Osteoarthritis &
Cartilage; 1999;
10329301100
28 Males: 40.4(Range: 42
e58); Females:
31.2(8.6);
11 Yes No No Yes No No No No No Cross-
sectional
7
Boegard T; Annals
of the Rheumatic
Diseases; 1999;
10343536101
58 Women: 40.4(Range:
42e58); Men:
57(49.5), (Range: 41
e57)
29 No No Yes Yes No No No No No Cross-
sectional
6
Adams JG; Clinical
Radiology; 1999;
1048421644
62 32 30 No No Yes Yes No No No Yes No Case
control
8
Pham XV; Revue du
Rhumatisme;
1999;
10526380102
10 10 10 67.2(7.34), (Range: 57
e80)
6 No No Yes No No No No No Yes Cross-
sectional
13
Gale DR;
Osteoarthritis &
Cartilage; 1999;
1055885043
291 233 58 No No No No No No No Yes No Case
control
10
Kladny B;
International
Orthopaedics;
1999;
1065329059
26 Yes No No Yes No No No No No Cross-
sectional
6
Zanetti M;
Radiology; 2000;
10831707103
16 16 0 67(Range:
43e79)
15 Yes No No Yes No Yes Yes No No Cross-
sectional
6
(continued on next page)
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Table I (continued )
Reference:
Author, Journal,
Year, PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs,
mean(SD),
range
No.
(%) of
females
Quantitative
cartilage
Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Score of
methodo
logical
quality
Jones G; Arthritis &
Rheumatism;
2000;
11083279 104
92 92 0 Boys: 12.8(2.7);
Girls: 12.6(2.9)
43 Yes No No Yes No Yes No No No Cross-
sectional
13
McCauley TR;
American
Journal of
Roentgenology;
2001;
11159074105
193 40(Range:
11e86)
83 No No Yes Yes No No No Yes Yes Cross-
sectional
8
Wluka AE; Annals
of the Rheumatic
Diseases; 2001;
11247861106
81 42 39 Cases: 58(6.1);
Controls: 56(5.4)
81(100%) Yes No Yes Yes No No No No No Case control 16
Felson DT; Annals
of Internal
Medicine; 2001;
1128173614
401 401 0 66.8 No No Yes No No No Yes No No Cross-
sectional
13
Hill CL; Journal of
Rheumatology;
2001;
1140912715
458 433 25 67 (34%) No No Yes No Yes No No No No Case control 13
Kawahara Y;
Journal of
Computer
Assisted
Tomography;
2001;
11584226107
35 57(Range:
33e70)
23 No No Yes Yes No No No Yes No Cross-
sectional
8
Arokoski JP; Annals
of the Rheumatic
Diseases; 2002;
11796401108
57 27 30 Cases: 56.2(4.9),
(Range: 47e64);
Controls: 56.3(4.5),
(Range: 47e64)
0 Yes No No No No No No No No Case control 8
Bergin D; Skeletal
Radiology; 2002;
11807587109
60 30 30 Cases: 50;
Controls: 57
No No Yes No No No No Yes Yes Case control 9
Beuf O; Arthritis &
Rheumatism;
2002;
11840441110
46 18 28 Mild OA:
68(9.1);
Severe OA:
70(6.3)
17 Yes No No No No No No No No Case control 5
Arokoski MH;
Journal of
Rheumatology;
2002;
12375331111
57 27 30 Cases: 56.2(4.9),
(Range: 47e64);
Controls: 56.3(4.5),
(Range: 47e64)
0 Yes No No Yes No No No No No Case control 8
Bhattacharyya T;
Journal of Bone &
Joint Surgery -
American
Volume; 2003;
1253356516
203 154 49 Cases: 65;
Controls: 67
No No Yes No No No No Yes No Case control 9
Link TM; Radiology;
2003;
1256312817
50 50 0 63.7(11.5),
(Range: 43e81)
30 No No Yes Yes No No No Yes Yes Cross-
sectional
6
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Tiderius CJ;
Magnetic
Resonance in
Medicine; 2003;
12594751112
17 50(Range:
35e70)
4 No Yes No Yes No No No No No Cross-
sectional
6
Cicuttini FM;
Arthritis &
Rheumatism;
2003;
1263242128
252 60.2(10) 157962%) Yes No No Yes No Yes No No No Cross-
sectional
9
Cicuttini FM;
Clinical &
Experimental
Rheumatology;
2003;
12673893113
81 42 39 ERT: 58(6.1); Controls:
56(5.4)
81(100%) Yes No No Yes No Yes No No No Case control 12
Sowers MF;
Osteoarthritis &
Cartilage; 2003;
1280147818
120 60 60 no OAK,
no Pain: 45(0.8); OAK,
no Pain:
46(0.6); No OAK,
Pain: 47(0.8);
OAK and Pain:
47(0.7)
(100%) No No Yes Yes No No Yes No No Case control 11
McGibbon CA;
Osteoarthritis &
Cartilage; 2003;
1281461160
4 No No Yes Yes No No No No No Other 5
Cicuttini FM;
Clinical &
Experimental
Rheumatology;
2003;
1284605046
157 157 0 62(10) (62%) Yes No No Yes No No No No No Cross-
sectional
10
Felson DT; Annals
of Internal
Medicine; 2003;
1296594151
256 256 0 Followed: 66.2(9.4);
Not
followed:
67.8(9.6)
(38.3%) No No Yes No No No Yes No No Longitudinal
prospective
11
Tarhan S; Clinical
Rheumatology;
2003;
14505208114
74 58 16 OA Patients:
57.4(8.5),
(Range: 45e75);
Healthy
controls: 59.1(5.8),
(Range: 46e77)
60 Yes No Yes Yes Yes No No No No Case
control
8
Hill CL; Arthritis &
Rheumatism;
2003;
1455808919
451 427 Knee pain/ROA/Male:
68.3; Knee pain/ROA/
Female: 65; No knee
pain/ROA/Male: 66.8;
No knee pain/ROA/
Female: 66.1
No No Yes No No No Yes No No Cross-
sectional
10
Kim YJ; Journal of
Bone & Joint
Surgery -
American
Volume; 2003;
14563809115
43 30(Range:
11e47); Median¼ 31
40 No Yes No Yes No No No No No Other 5
(continued on next page)
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Table I (continued )
Reference:
Author, Journal,
Year, PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs,
mean(SD),
range
No.
(%) of
females
Quantitative
cartilage
Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Score of
methodo
logical
quality
Lindsey CT;
Osteoarthritis &
Cartilage; 2004;
1472386829
74 33 21 Controls:
34.2(12.5); OA1
(KL1/2): 62.7(10.9);
OA2(KL3/4):
66.6(11.6)
39 Yes No No Yes No Yes No No No Case
control
8
Jones G;
Osteoarthritis &
Cartilage; 2004;
1472387647
372 186 186 45(Range:
26e61)
Yes No No Yes No Yes No No No Case
control
9
Raynauld JP;
Arthritis &
Rheumatism;
2004;
1487249048
32 32 0 62.9(8.2) (74%) Yes No No Yes No No No No No Longitudinal
Prospective
10
Wluka AE; Annals
of the Rheumatic
Diseases; 2004;
1496296020
132 132 0 63.1(Range:
41e86)
71(54%) Yes No No Yes No No No No No Longitudinal
Prospective
10
Cicuttini F;
Rheumatology;
2004;
1496320152
117 117 0 67(10.6) (58%) Yes No No Yes No No No No No Longitudinal
Prospective
12
Peterfy CG;
Osteoarthritis &
Cartilage; 2004;
14972335116
19 19 0 61(8) 4 No No Yes Yes Yes Yes Yes Yes Yes Other 5
Graichen H;
Arthritis &
Rheumatism;
2004;
15022323117
21 21 0 70.6(7.7),
(Range:
58e86)
17 Yes No No Yes No Yes No No No Cross-
sectional
6
Dashti M;
Scandinavian
Journal of
Rheumatology;
2004;
15163109118
174 117 57 61.6(9.5) 123(70.7%) Yes No No Yes No No No No No Case
control
11
Arokoski JP; Journal
of Clinical
Densitometry;
2004;
15181262119
57 27 30 Cases: 56.2(4.9),
Range: (47e64);
Controls: 56.3(4.5),
(Range: 47e64)
0 No Yes No No No No No No No Case
control
9
Dunn TC;
Radiology;
2004;
15215540120
55 48 7 Healthy: 38(Range:
22e71); Mild OA:
63(Range: 46e81);
Severe OA: 67
(Range: 43e88)
30 No Yes No Yes No No No No No Case
control
8
Regatte RR;
Academic
Radiology;
2004;
15217591121
14 6 8 Asymptomatic:
33.5(Range:
22e45);
Symptomatic:
45.5(Range:
28e63)
2 No Yes No Yes No No No No No Case control 7
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Baysal O; Swiss
Medical
Weekly; 2004;
15243849122
65 65 0 53.1(7),
(Range: 45e75)
65(100%) Yes No Yes Yes No Yes No No No Cross-sectional 7
Lerer DB; Skeletal
Radiology; 2004;
15316679123
205 46.5(Range:
15e88);
Median¼ 46
113 No No Yes Yes No No No Yes No Cross-sectional 6
Berthiaume MJ;
Annals of the
Rheumatic
Diseases; 2005;
1537485578
32 Yes No Yes Yes No No No Yes No Longitudinal
Prospective
10
King KB; Magnetic
Resonance
Imaging; 2004;
15527998124
16 16 0 Males:
Median¼ 58.5,
(11.3), (Range:
43e76); Females:
Median¼ 70 (14.4),
(Range: 46e88)
8(50%) Yes Yes No Yes No No No No No Cross-sectional 7
Carbone LD;
Arthritis &
Rheumatism;
2004;
15529367125
818 Non-users:
74.8(2.94);
Antiresportive users:
74.8(2.9)
818(100%) No No Yes Yes Yes Yes No No No Cross-sectional 11
Cicuttini F;
Journal of
Rheumatology;
2004;
15570649126
123 Yes No No Yes No No No No No Longitudinal
Prospective
6
Wluka AE; Annals
of the Rheumatic
Diseases; 2005;
1560174238
149 68 81 Normal:
57(5.8); OA:
63(10.3)
1499(100%) No No No No No Yes No No No Longitudinal
Prospective
13
Ding C;
Osteoarthritis &
Cartilage; 2005;
1572788549
372 162 210 No cartilage
defects: 43.6(7.1);
Any cartilage
defect: 47(6.1)
(56.5%) Yes No Yes Yes No No No No No Case control 9
Hill CL; Arthritis &
Rheumatism;
2005;
1575106445
433 360 73 Cases males: 68.2;
Cases females:
65; Control males:
66.8; Control
females: 65.8
143 No No Yes No No No No No Yes Case control 12
Kornaat PR;
European
Radiology; 2005;
15754163127
205 205 0 Median¼ 60;
(Range: 43e77)
163(80%) No No Yes Yes No No Yes Yes No Cross-sectional 8
Zhai G; Arthritis &
Rheumatism;
2005;
15818695128
151 23 128 Men: 64(8.1);
Women: 62(7.7)
72 Yes No No Yes No No No No No Cross-sectional 8
Cicuttini F;
Osteoarthritis &
Cartilage; 2005;
1592263450
28 28 0 62.8(9.8) (57%) Yes No No Yes No No No No No Longitudinal
Prospective
10
Blankenbaker
DG; Skeletal
Radiology; 2005;
15940487129
247 74 173 44 126 No No Yes Yes No No No Yes Yes Cross-
sectional
6
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Table I (continued )
Reference:
Author, Journal,
Year, PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs,
mean(SD),
range
No.
(%) of
females
Quantitative
cartilage
Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesi s
Meniscus Ligament Study
design
Score of
methodo
logical
quality
Huh YM; Korean
Journal of
Radiology; 2005;
15968151130
94 73 21 RA group: 49.2
(Range: 37e76),
Median¼ 48;
OA group: 57.8
(Range: 40e80),
Median¼ 58
73 No No Yes No Yes No No No No Longitudinal
Retrospective
7
von
Eisenhart-Roth;
Annals of the
Rheumatic
Diseases; 2006;
15975965131
26 26 0 70.4(7.6),
(Range:
58e86)
20 Yes No No Yes No No No No No Cross-
sectional
5
Tan AL; Arthritis &
Rheumatism;
2005;
16052535132
58 40 18 Early OA: 56
(Range: 49e69);
Chronic OA: 60
(Range: 51e68);
Hand OA: 60
(Range: 46e72);
44 No No Yes Yes Yes Yes Yes No Yes Cross-
sectional
7
Lo GH; Arthritis &
Rheumatism;
2005;
16145676133
268 80 188 No BMLs:
64.8(8.5); Medial
BMLs: 68.3(7); Lateral
BMLs:
66.6(9.5)
(59%) No No Yes No No No Yes No No Cross-
sectional
10
Li X; Magnetic
Resonance in
Medicine; 2005;
16155867134
19 9 10 Cases: Median¼ 52,
(Range: 18e72);
Controls:
Median¼ 30,
(Range: 22e74)
8 No Yes No Yes No No No No No Case control 7
Rhodes LA;
Rheumatology;
2005;
16188949135
35 35 0 Median¼ 63; (Range:
49e77)
23 No No Yes No Yes No No No No Cross-
sectional
9
Williams A;
Arthritis &
Rheumatism;
2005;
1625502432
31 31 0 67(10.4), 9
(Range: 45e86)
24(77%) No Yes No Yes No No No No No Cross-
sectional
9
Loeuille D;
Arthritis &
Rheumatism;
2005;
16255041136
39 39 0 56.4(12.71) (56.4%) No No Yes No Yes No No No No Cross-
sectional
10
Roos EM; Arthritis
& Rheumatism;
2005;
16258919137
30 45.8(3.3) 10(33.3%) No Yes No Yes No No No No No Randomized
controlled
trial
17
Hunter DJ;
Journal of
Rheumatology;
2005;
1626570253
132 162 0 33.5(9.7) (44.2%) No No Yes Yes No Yes No Yes Yes Cross-
sectional
8
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Nojiri T; Knee
Surgery, Sports
Traumatology,
Arthroscopy;
2006;
1639556433
28 9 21 40.3(Range:
16e74)
17 No Yes No Yes No No No No No Cross-
sectional
7
Kimelman T; Invest
Radiol; 2006;
16428993138
7 4 3 Healthy
controls: 23;
OA cases: 56
4 No Yes No Yes No No No No No Other 6
Sengupta M;
Osteoarthritis &
Cartilage; 2006;
16442316139
217 217 0 67.3(9.1) (30%) No No Yes Yes Yes Yes Yes No No Cross-
sectional
7
Hunter DJ; Arthritis
& Rheumatism;
2006;
1650893081
257 257 0 66.6(9.2),
(Range: 47e93)
(41.6%) No No Yes Yes No No No Yes No Longitudinal
Prospective
10
Hunter DJ; Arthritis
& Rheumatism;
2006;
1664603783
217 217 0 66.4(9.4) (44%) No No Yes Yes No No Yes No No Longitudinal
Prospective
10
Grainger AJ;
European
Radiology; 2007;
16685505140
43 43 0 64(Range:
48e75)
19 No No Yes No Yes No No Yes No Cross-
sectional
8
Cashman PM; IEEE
Transactions on
Nanobioscience;
2002;
16689221141
27 10 17 OA patients:
(Range: 45e73);
Similar age
controls: (Range:
50e65); Young
healthy controls:
(Range: 21e32);
8(29.6%) Yes No No Yes No No No No No Other 6
Torres L;
Osteoarthritis &
Cartilage; 2006;
1671331021
143 143 0 70(10) (78%) No No Yes Yes Yes Yes Yes Yes Yes Cross-
sectional
9
Kornaat PR;
Radiology; 2006;
1671446322
205 97 103 60
(Range:
43e77)
163(80%) No No Yes Yes Yes Yes Yes Yes No Cross-
sectional
9
Bamac B; Saudi
Medical Journal;
2006;
16758050142
46 36 10 Cases: 41.9
(Range: 20e67);
Controls: 39.7
(Range: 21e66)
25 No No No No No No No Yes No Case
control
8
Boks SS; American
Journal of Sports
Medicine; 2006;
16861575143
134 136 132 40.8(Range:
18.8e63.8)
No No Yes Yes No No No Yes Yes Cross-
sectional
7
Koff MF;
Osteoarthritis &
Cartilage; 2007;
1694931334
113 113 0 56(11),
(Range:
33e82)
84 No Yes No Yes No No No No No Cross-
sectional
8
Nakamura M;
Magnetic
Resonance
Imaging; 2006;
1707133639
63 51.8
(Range:
40e59)
42 No No Yes No No No No Yes No Cross-
sectional
6
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Table I (continued )
Reference:
Author, Journal,
Year, PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs,
mean(SD),
range
No.
(%) of
females
Quantitative
cartilage
Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Score of
methodo
logical
quality
Folkesson J; IEEE
Transactions
on Medical
Imaging; 2007;
17243589144
139 56(Range:
22e79)
(59%) Yes No No Yes No No No No No Other 7
Li X; Osteoarthritis
& Cartilage;
2007;
1730736535
26 10 16 Healthy: 41.3
(Range: 22e74);
OA patients: 55.9
(37e72)
11 No Yes Yes Yes No Yes Yes Yes Yes Case control 7
Iwasaki J; Clinical
Rheumatology;
2007;
17322963145
26 26 0 63.8(Rang:
49e82)
18 No No No No No No No No No Cross-
sectional
5
Dam EB;
Osteoarthritis &
Cartilage; 2007;
1735313231
139 Evaluation set:
55(Range: 21e78);
Scan-rescan set: 61
(Range: 26e75)
(54.5%) Yes No No Yes No No No No No Other 9
Tiderius CJ;
Magnetic
Resonance in
Medicine; 2007;
17390362146
18 10 8 Controls: 28(Range:
20e47); Cases: 39
(Range: 25e58)
No Yes No Yes No No No No No Case
control
6
Baranyay FJ;
Seminars in
Arthritis &
Rheumatism;
2007;
17391738147
297 297 58(5.5) (63%) Yes No No Yes No No Yes No No Cross-
sectional
16
Issa SN; Arthritis
& Rheumatism;
2007;
1739422554
146 146 0 70 109 No No Yes Yes No Yes Yes Yes No Cross-
sectional
8
Hanna F;
Menopause;
2007;
17413649148
176 0 176 52.3(6.6),
(Range:
40e67)
176(100%) Yes No No Yes No No No No No Cross-
sectional
13
Hunter DJ; Annals
of the Rheumatic
Diseases; 2008;
1747299523
71 67.9(9.3) (28.2%) No No Yes Yes Yes Yes Yes Yes Yes Other 8
Hill CL; Annals of
the Rheumatic
Diseases; 2007;
1749109624
270 270 0 66.7(9.2) 112 No No Yes Yes Yes No No No No Longitudinal
Prospective
9
Qazi AA;
Osteoarthritis &
Cartilage; 2007;
17493841149
71 Yes No No Yes No No No No No Cross-
sectional
8
Lammentausta E;
Osteoarthritis &
Cartilage; 2007;
17502160150
14 55(18) 2 No Yes No Yes No Yes No No No Other 5
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Guymer E;
Osteoarthritis &
Cartilage; 2007;
17560134151
176 0 176 52.3(6.6) 176(100%) Yes No Yes Yes No Yes Yes No No Cross-
sectional
11
Nishii T;
Osteoarthritis &
Cartilage; 2008;
17644363152
33 23 10 Volunteers:
34(Range:
23e51); Patients:
40(Range: 22e69)
33(1005) No Yes No Yes No No No No No Case
control
8
Janakiramanan N;
Journal of
Orthopaedic
Research;
2008;
1776345155
202 74 128 61(9) (73%) No No Yes Yes No No No No No Cross-
sectional
11
Lo GH;
Osteoarthritis &
Cartilage; 2008;
17825586153
845 170 63.6(8.8) (58%) No No Yes No No No No Yes No Cross-
sectional
10
Davies-Tuck M;
Osteoarthritis &
Cartilage; 2008;
17869546154
100 100 0 63.3(10.2) 61(61%) Yes No No Yes No No No No No Longitudinal
Prospective
11
Qazi AA; Academic
Radiology; 2007;
17889338155
159 (Range:
21e81)
No No Yes Yes No No No No No Other 8
Folkesson J;
Academic
Radiology; 2007;
17889339156
71 56(Range:
22e79)
(59%) No No No No No No No No No Other 7
Englund M;
Arthritis &
Rheumatism;
2007;
1805020140
310 102 208 Cases: 62.9(8.3);
Controls:
61.2(8.3)
211(68%) No No Yes No No No No Yes No Case
control
15
Kamei G; Magnetic
Resonance
Imaging; 2008;
18083319157
37 27 0 Cartilage defect:
51.6(Range:
42e61); No
cartilage defect:
54.5(Range:
45e61)
20 No No Yes Yes No No No Yes No Case
control
7
Li W; Journal of
Magnetic
Resonance
Imaging; 2008;
18183573158
29 19 10 OA subjects:
61.7(Range: 40e86);
Controls: 31
(Range: 18e40)
19 No Yes No Yes No No No No No Cross-
sectional
5
Amin S;
Osteoarthritis &
Cartilage; 2008;
1820362986
265 265 67(9) (43%) No No Yes Yes No No No Yes Yes Longitudinal
Prospective
11
Taljanovic MS;
Skeletal
Radiology; 2008;
18274742159
19 19 0 66 8 No Yes No No No No No No No Case
control
8
Oda H; Journal of
Orthopaedic
Science; 2008;
18274849160
161 58.5(Range:
11e85)
98 No No Yes No Yes No No Yes Yes Cross-
sectional
8
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Table I (continued )
Reference:
Author, Journal,
Year, PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs,
mean(SD),
range
No.
(%) of
females
Quantitative
cartilage
Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Score of
methodo
logical
quality
Hanna FS; Arthritis
Research &
Therapy; 2008;
18312679161
176 52.3(6.6) (100%) Yes No No Yes No No No No No Cross-
sectional
10
Reichenbach S;
Osteoarthritis &
Cartilage; 2008;
1836741541
964 217 747 63.3 (57%) No No Yes Yes No Yes No No No Cross-
sectional
8
Petterson SC;
Medicine &
Science in Sports
& Exercise;
2008;
18379202162
123 123 0 64.9(8.5) 67 No No No No No No No No No Case control 11
Bolbos RI;
Osteoarthritis &
Cartilage; 2008;
18387828163
32 16 16 Cases:
47.2(11.54), (Range:
29e72);
Controls:
36.3(10.54),
(Range: 27e56)
14 Yes Yes No Yes No Yes No No No Case control 7
Quaia E; Skeletal
Radiology;
2008;
18404267164
35 35 0 42(17),
(Range: 22e67)
14 No Yes No Yes No No No No No Other 6
Folkesson J;
Magnetic
Resonance in
Medicine;
2008;
1850684542
245 143 KL0: 48(Range:
21e78); KL1:
62(Range:
37e81);
KL2: 67(Range:
47e78); KL3&4:
68(Range:
58e78)
No No No Yes No No No No No Other 12
Mills PM;
Osteoarthritis &
Cartilage; 2008;
18515157165
49 25 24 APMM:
46.8(5.3);
Controls:
43.6(6.6)
18(36.7%) Yes No Yes Yes No No No No No Case control 12
Dore D;
Osteoarthritis &
Cartilage; 2008;
18515160166
50 50 64.5(7.1) 23 Yes No Yes Yes No Yes No No No Cross-
sectional
9
Mutimer J; Journal
of Hand Surgery;
2008;
18562375167
20 20 0 47
(Range: 26e69)
9 No No Yes Yes No No No No No Cross-
sectional
6
Amin S; Journal of
Rheumatology;
2008;
18597397168
192 192 69(9) 0. No No Yes Yes No No No No No Cross-
sectional
10
Li X; Journal
of Magnetic
Resonance
Imaging; 2008;
18666183169
38 13 25 Healthy: 28.5
(Range: 20e34); Knee
OA
or injury: 37.4 (Range:
20e66)
10 Yes No No Yes No No Yes No No Other 7
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Pelletier JP;
Osteoarthritis
& Cartilage;
2008;
1867238625
27 1 64.1(9.6) 14 No No Yes Yes Yes Yes Yes Yes No Other 9
Stahl R; European
Radiology; 2009;
18709373170
37 17 20 Mild OA:
54(9.98);
Healthy control:
33.6(9.44)
19 No Yes Yes Yes No No No No No Case
control
10
Brem MH; Acta
Radiologica;
2008;
18720084171
23 23 0 55.5(10.3) 8 No No Yes No No No Yes No No Other 6
Lancianese SL;
Bone; 2008;
18755303172
4 80(14) 3 No No No No No Yes No No No Cross-
sectional
5
Englund M; New
England Journal
of Medicine;
2008;
1878410026
991 171 62.3(8.6),
(Range:
50.1e90.5)
565(57%) No No Yes No No No No Yes No Cross-
sectional
10
Mamisch TC;
Magnetic
Resonance
in Medicine;
2008;
18816842173
26 No Yes No Yes No No No No No Cross-
sectional
7
Rauscher I;
Radiology;
2008;
18936315174
60 37 23 Healthy
controls:
34.1(10);
Mild OA:
52.5(10);
Severe OA:
61.6(11.6)
32 No Yes No Yes No No No Yes No Case control 9
Li W; Journal
of Magnetic
Resonance
Imaging; 2009;
19161210175
31 17 14 OA patients:
61.8(Range:
40e86);
Healthy
controls: 29.2(Range:
18e40)
21 No Yes No Yes No No No No No Case control 7
Choi JW; Journal
of Computer
Assisted
Tomography;
2009;
19188805176
36 39.7(Range:
8e69)
21 No No Yes Yes No No No Yes No Longitudinal
Retrospective
7
Chen YH; Journal
of Computer
Assisted
Tomography;
2008;
19204464177
96 25 71 OA patients:
56; Non-OA: 46
No No Yes Yes No No No Yes No Case control 8
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Table II
Summary of Concurrent Validity of MRI in OA
Outcome of
interest
Number of
studies
examining
this outcome
Number of
studies ﬁnding
signiﬁcant
associations (P< .05)
Symptoms 21 studies 13 of 21 (62%)
Radiographic features 43 studies 39 of 43 (90%)
Radiographic joint space 9 studies 9 of 9 (100%)
Alignment 10 studies 9 of 10 (90%)
CT 4 studies 4 of 4 (100%)
Histology/Pathology 5 studies 3 of 5 (60%)
Arthroscopy 7 studies 5 of 7 (71%)
D.J. Hunter et al. / Osteoarthritis and Cartilage 19 (2011) 557e588572subluxation of the meniscus, meniscal tears, or Baker cysts,
were not associated with symptoms22.
 Maximal bone marrow lesion (BML) size on the Boston Leeds
Osteoarthritis Score (BLOKS) scale had a positive linear relation
with VAS pain (P for linear trend¼ 0.04)23.
 No correlation of baseline synovitis with baseline pain score
(r¼ 0.09, P¼ 0.17)24.
 No relation between baseline synovitis score and VAS pain
score (r¼ 0.11, P¼ 0.60)25.
 In the group of persons with radiographic evidence of osteo-
arthritis (KellgreneLawrence grade 2 or higher), the preva-
lence of a meniscal tear was 63% among those with knee pain,
aching, or stiffness on most days and 60% among those without
these symptoms (P¼ 0.75); the corresponding prevalences in
the groupwithout radiographic evidence of osteoarthritis were
32% and 23% (P¼ 0.02). The majority of the meniscal tears e
180 of 297 (61%) were in subjects who had not had any pain,
aching, or stiffness in the previous month26.
Relation to radiographic features
43 studies examined the concurrent relation of MRI ﬁndings in
OA to radiographic features. Of these, 90% demonstrated a statisti-
cally signiﬁcant association, deﬁned as P< 0.05.
Relation of quantitative cartilage morphometry measures to
radiographic abnormalities.
 Signiﬁcant differences in lateral and medial femorotibial
cartilage thickness were found between those with and
without radiographic OA. Signiﬁcant cartilage thinning could
be detected by MRI in patients with OA, even when the joint
space was normal radiographically27.
 For every increase in grade of lateral tibiofemoral osteophytes
the lateral tibial cartilage volume was signiﬁcantly reduced by
255 mm3, after adjustment. There was a reduction of 77 mm3
in medial tibial cartilage volume for every increase in grade of
medial tibiofemoral osteophytes, but this ﬁnding was only of
borderline statistical signiﬁcance28.
 Cartilage volume and thickness were less in patients with OA
compared to normal controls (P< 0.1)29.
 Kellgren and Lawrence (KLG)2 participants displayed, on
average, thicker cartilage than healthy controls in the medial
femorotibial compartment [particularly anterior subregion of
the medial tibia (MT) and peripheral (external, internal)
subregions of the medial femur], and in the lateral femur. KLG3
participants displayed signiﬁcantly thinner cartilage than KLG0
participants in the medial weight-bearing femur (central
subregion), in the external subregion of the MT, and in the
internal subregion of the lateral tibia30. Mean cartilage signal intensity provided a clear separation of
healthy from KLG1 (P¼ 0.0009). Quantiﬁcation of cartilage
homogeneity by entropy was able to clearly 11separate healthy
from OA subjects (P¼ 0.0003). Furthermo121re, entropy was
also able to separate healthy from KL 1 subjects (P¼ 0.0004)31.Relation of other MRI measures to radiographic abnormalities.
 Signiﬁcant difference (P¼ 0.002) in the average T(1rho) within
patellar and femoral cartilage between controls
(45.04 2.59 ms) and osteoarthritis patients (53.06 4.60 ms).
A signiﬁcant correlation was found between T(1rho) and T(2);
however, the difference of T(2) was not statistically signiﬁcant
between controls and osteoarthritis patients31.
 Trend toward a lower dGEMRIC index with increasing KLG; the
spared compartments of knees with a KLG grade 2 had a higher
dGEMRIC index than those of knees with a KLG grade 4 (mean
425 msec vs 371 msec; P< 0.05)32.
 All cases demonstrating decreased T1 values on dGEMRIC,
showed abnormal arthroscopic or direct viewing ﬁndings. The
diagnosis of damage in articular cartilage was possible in all 16
cases with radiographic KLG 1 on dGEMRIC, while the intensity
changes were not found in 10 of 16 cases on Proton density
Weighted Image (PDWI)33.
 No differences of T2 values were found across the stages of OA
(P¼ 0.25), but the factor of BMI did have a signiﬁcant effect
P< 0.0001) on T2 value34.
 Average T(1rho) and T(2) values were signiﬁcantly increased in
OA patients compared with controls [52.04 2.97 ms vs
45.53 3.28 ms with P¼ 0.0002 for T(1rho), and
39.63 2.69 ms vs 34.74 2.48 ms with P¼ 0.001 for T(2)].
IncreasedT(1rho) andT(2) valueswere correlatedwith increased
severity in radiographic and MR grading of OA. T(1rho) has
a larger range and higher effect size than T(2), 3.7 vs 3.035.
 Statistically signiﬁcant correlation between radiography and
MR cartilage loss in the medial (r 0.7142, P .0001) and lateral
compartments (r¼ 0.4004, P .0136). Signiﬁcant correlations
also found between radiographic assessment of sclerosis and
osteophytes and those found on MRI36.
 Patients in whom plain radiographs, MRI, and arthroscopy
were compared, the plain radiographs and MRI signiﬁcantly
underestimated the extent of cartilage abnormalities37.
 Presence of synovial thickening was more likely with
increasing KLG, from 24.0% in those with KLG 0e78.3% in those
with KLG 3/4 (P< 0.001)15.
 Higher KLG was correlated with a higher frequency of meniscal
tears (r¼ 0.26, P< 0.001)16.
 KLG correlated signiﬁcantly (P< 0.05) with the grade of cartilage
lesions, and a substantially higher percentage of bone marrow
and meniscal lesions with higher KLG found on MR images17.
 Women with osteoarthritis had larger medial and lateral tibial
plateau bone area [mean (SD): 1850 (240) mm2 and 1279 (220)
mm2, respectively] than healthy women [1670 (200) mm2 and
Table III
Summary table of studies reporting data on predictive validity of MRI in knee OA
Reference: Author,
Journal, Year,
PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs,
Mean(SD),
Range
No. (%)
of females
Quantitative
cartilage
Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Score of
methodological
quality
Boegard TL;
Osteoarthritis &
Cartilage; 2001;
11467896178
47 Women:
Median¼ 50,
(Range: 42e57);
Men: Median¼ 50,
(Range: 41e57)
25(53.2%) No No Yes Yes No No No Yes No Longitudinal
Prospective
9
Wluka AE; Arthritis &
Rheumatism; 2002;
12209510179
123 123 0 63.1(10.6) 71 Yes No No Yes No Yes No No No Longitudinal
Prospective
14
Cicuttini FM; Journal of
Rheumatology;
2002; 12233892180
21 8 13 Case: 41.3(13.2);
Controls: 49.2(17.8)
14(66.7%) Yes No No Yes No No No No No Longitudinal
Retrospective
13
Biswal S; Arthritis &
Rheumatism; 2002;
1242822876
43 4 39 54.4(Range:
17e65)
21 No No Yes Yes No No Yes Yes Yes Longitudinal
Retrospective
8
Cicuttini F; Journal of
Rheumatology;
2002; 12465162181
110 110 0 63.2(10.2) 66 Yes No No Yes No No No No No Longitudinal
Prospective
12
Pessis E; Osteoarthritis
& Cartilage; 2003;
12744942182
20 20 63.9(9) 13 Yes No Yes Yes No Yes Yes No No Longitudinal
Prospective
12
Felson DT; Annals of
Internal Medicine;
2003; 1296594151
256 156 0 Followed:
66.2(9.4); Not
followed: 67.8(9.6)
(38.3%) No No Yes No No No Yes No No Longitudinal
Prospective
11
Cicuttini FM; Arthritis &
Rheumatism; 2004;
1473060477
117 117 63.7(10.2) (58.1%) Yes No No Yes No No No No No Longitudinal
Prospective
9
Wluka AE; Annals of
the Rheumatic
Diseases; 2004;
1496296020
132 132 0 63.1(Range: 41
e86)
71(54%) Yes No No Yes No No No No No Longitudinal
Prospective
10
Cicuttini F;
Rheumatology;
2004; 1496320152
117 117 0 67(10.6) (58%) Yes No No Yes No No No No No Longitudinal
Prospective
12
Cicuttini FM; Ann
Rheum Dis; 2004;
1511571465
123 123 0 Joint replacement:
64.1(9.3); No joint
replacement:
63.1(10.3)
65(52.8%) Yes No No Yes No No No No No Longitudinal
Prospective
11
Dashti M;
Scandinavian Journal
of Rheumatology;
2004; 15163109118
174 117 57 61.6(9.5) 123(70.7%) Yes No No Yes No No No No No Case control 11
Cicuttini FM; Journal of
Rheumatology;
2004; 15229959183
102 102 0 63.8(10.1) (63%) Yes No No Yes No No No No No Longitudinal
Prospective
10
Berthiaume MJ; Annals
of the Rheumatic
Diseases; 2005;
1537485578
32 Yes No Yes Yes No No No Yes No Longitudinal
Prospective
10
Cicuttini F; Journal of
Rheumatology;
2004; 15570649126
123 Yes No No Yes No No No No No Longitudinal
Prospective
6
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Table III (continued )
Reference: Author,
Journal, Year,
PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs,
Mean(SD),
Range
No. (%)
of females
Quantitative
cartilage
Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Score of
methodological
quality
Cubukcu D; Clinical
Rheumatology;
2005; 15599642 184
40 40 HA group:
52.6(7.16); Saline
group: 57.6(2.77)
24(60%) No No Yes Yes No Yes No Yes Yes Randomized
controlled trial
15
Ozturk C; Rheumatol
Int;
2006;15703953185
47 47 0 HA-only group:
58(7.7);
HA&Cortico group:
58.1(10.3)
39(97.5%) No No Yes Yes No No Yes No No Randomized
controlled trial
17
Wang Y; Arthritis Res
Ther; 2005;
15899054186
126 126 63.6(10.1) 68 No No No No No Yes No No No Longitudinal
Prospective
12
Cicuttini F;
Osteoarthritis &
Cartilage; 2005;
1592263450
28 28 0 62.8(9.8) (57%) Yes No No Yes No No No No No Longitudinal
Prospective
10
Wluka AE;
Rheumatology;
2005; 1603008466
126 126 0 63.6(10.1) 68(54%) Yes No Yes Yes No Yes No No No Longitudinal
Prospective
14
Garnero P; Arthritis &
Rheumatism; 2005;
16145678187
377 377 0 62.5(8.1) (76%) No No Yes Yes No No No No No Longitudinal
Prospective
11
Wang Y;
Rheumatology;
2006; 1618894779
124 124 0 Females: 57.1(5.8);
Males: 52.5(13.2)
81(65.3%) No No Yes Yes No Yes No No No Longitudinal
Prospective
11
Phan CM; European
Radiology; 2006;
1622253368
40 34 6 57.7(15.6), (Range:
28e81)
16 No No Yes Yes No Yes Yes Yes Yes Longitudinal
Prospective
7
Hayes CW; Radiology;
2005; 16251398188
117 117 115 No OA, No Pain:
44.6(10.7); OA, No
Pain: 16.2(0.8); No
OA, Pain: 47(0.7);
OA&Pain: 47.1(0.8)
(100%) No No Yes Yes Yes Yes Yes Yes Yes Longitudinal
Prospective
13
Wang Y; Journal of
Rheumatology;
2005; 16265703189
40 0 40 52.3(13) 0 Yes No No Yes No Yes No No No Longitudinal
Prospective
11
Ding C; Arthritis &
Rheumatism; 2005;
1632033980
325 45.2(6.5) 190 Yes No Yes Yes No No No No No Longitudinal
Prospective
10
Bruyere O; Annals of
the Rheumatic
Diseases; 2006;
16396978190
62 62 0 64.9(10.3) 49 Yes No Yes Yes Yes Yes Yes Yes Yes Longitudinal
Prospective
10
Katz JN; Osteoarthritis
& Cartilage; 2006;
1641321069
83 61(11), (Range:
45e89)
50(60%) No No Yes Yes Yes Yes Yes Yes No Longitudinal
Prospective
9
Raynauld JP; Arthritis
Research & Therapy;
2006; 1650711972
110 110 0 62.4(7.5) (64%) Yes No Yes Yes No No Yes Yes No Longitudinal
Prospective
11
Hunter DJ; Arthritis &
Rheumatism; 2006;
1650893081
257 257 0 66.6(9.2), (Range:
47e93)
(41.6%) No No Yes Yes No No No Yes No Longitudinal
Prospective
10
Ding C; Archives of
Internal Medicine;
2006; 1656760582
325 Decrease defects:
45.4(6.4); Stable
defects: 44.2(7.1);
Increase defects:
46.1(5.9)
(58.1%) No No Yes Yes No No No No No Longitudinal
Prospective
14
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Brandt KD;
Rheumatology;
2006; 16606655191
30 20 10 62 29 No No No No Yes No No No No Other 10
Hunter DJ; Arthritis &
Rheumatism;
2006; 1664603783
217 217 0 66.4(9.4) (44%) No No Yes Yes No No Yes N No Longitudinal
Prospective
10
Wluka AE; Arthritis
Research & Therapy;
2006; 16704746192
105 105 0 All eligible: 62.5
(10.7); MRI at FU:
63.8(10.6); Lost
to FU: 61.6(11.3)
59(53%) Yes No No Yes No Yes No N No Longitudinal
Prospective
17
Hunter DJ;
Osteoarthritis &
Cartilage; 2007;
16857393193
127 127 67(9.05) (46.7%) No Yes No Yes No No No N No Cross-sectional 12
Bruyere O;
Osteoarthritis &
Cartilage; 2007;
1689046173
62 62 0 64.9(10.3) 46 No No Yes Yes Yes Yes Yes Y s Yes Longitudinal
Prospective
10
Amin S; Annals of the
Rheumatic Diseases;
2007; 17158140194
196 196 0 68(9) 0 No No Yes Yes No No No N No Longitudinal
Prospective
13
Nevitt MC; Arthritis &
Rheumatism; 2007;
1746912674
80 39 0 73.5(3.1) (63.6%) No No Yes Yes No No No N No Longitudinal
Prospective
10
Hill CL; Annals of the
Rheumatic Diseases;
2007; 1749109624
270 270 0 66.7(9.2) 112 No No Yes Yes Yes No No N No Longitudinal
Prospective
9
Pelletier JP;
Arthritis Research
& Therapy; 2007;
1767289171
110 110 0 Q1 greatest loss
global: 63.7(7.2);
Q4 least loss gobal:
61.3(7.5);
Q1 greatest
loss_medial: 64.1
(7.4); Q1 least
loss_medial:
61.6(7.8)
(68.3%) No No Yes Yes No No Yes Y s No Longitudinal
Prospective
15
Davies-Tuck ML;
Osteoarthritis &
Cartilage; 2008;
17698376195
117 117 0 63.7(10.2) 68(58%) Yes No Yes Yes No Yes No N No Longitudinal
Prospective
14
Raynauld JP; Annals
of the Rheumatic
Diseases; 2008;
1772833384
107 107 0 62.4(7.5) (64%) Yes No Yes Yes No No No Y s No Longitudinal
Retrospective
15
Felson DT; Arthritis
& Rheumatism;
2007; 1776342770
330 110 220 Cases:
62.9(8.3);
Controls:
61.2(8.4)
211(63.9%) No No Yes No No Yes Yes N No Case control 12
Kornaat PR;
European
Radiology; 2007;
17823802 196
182 71 59(Range:
43e76)
157(80%) No No Yes No No No Yes N No Longitudinal
Prospective
8
Hunter DJ; Arthritis
Research & Therapy;
2007; 17958892197
160 80 80 67(9) (46%) No No Yes Yes No No No N No Case control 11
(continued on next page)
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Table III (continued )
Reference: Author,
Journal, Year,
PMID
Whole
sample
size
No. of
cases
No. of
controls
Age, yrs,
Mean(SD),
Range
No. (%)
of females
Quantitative
cartilage
Compositional
techniques
Semi-
quantitative
Cartilage Synovium Bone Bone
marrow
lesions
Meniscus Ligament Study
design
Score of
methodological
quality
Englund M;
Arthritis &
Rheumatism;
2007;
1805020140
310 102 208 Cases:
62.9(8.3)
211(68.1%) No No Yes No No No No Yes No Case control 15
Davies-Tuck ML;
Osteoarthritis &
Cartilage; 2008;
1809384785
74 0 74 Meniscal tear:
58.8(6); No
meniscal tear:
55.5(4.3)
74(100%) No Yes Yes Yes No Yes No Yes No Longitudinal
Prospective
13
Hernandez-Molina G;
Arthritis &
Rheumatism;
2008; 18163483198
258 258 0 66.6(9.2) (42.6%) No No Yes Yes No No Yes No Yes Longitudinal
Prospective
11
Teichtahl AJ;
Osteoarthritis &
Cartilage; 2009;
18194873199
99 99 0 63 (10) (60%) Yes No No Yes No Yes No No No Longitudinal
Prospective
14
Amin S; Osteoarthritis
& Cartilage; 2008;
1820362986
265 265 67(9) (43%) No No Yes Yes No No No Yes Yes Longitudinal
Prospective
11
Teichtahl AJ; Obesity;
2008; 18239654200
297 297 58(5.5) 186 Yes No Yes Yes No Yes No No No Longitudinal
Prospective
14
Blumenkrantz G;
Osteoarthritis &
Cartilage; 2008;
18337129201
18 8 10 Cases:
55.7(7.3);
Controls:
57.6(6.2)
18(100%) No Yes Yes Yes No No No No No Case control 12
Song IH; Annals
of the Rheumatic
Diseases; 2009;
18375537202
41 41 65(6.7) 26 No No Yes No No No No No Yes Randomized
controlled trial
14
Scher C; Skeletal
Radiology;
2008;
1846386567
65 65 0 OA-only: 49.3
(Range: 28e75);
OA&BME group:
53.5(35e82)
No No Yes Yes No No Yes No No Longitudinal
Retrospective
10
Sharma L; Arthritis &
Rheumatism;
2008; 1851277787
153 153 0 66.4(11) Yes No Yes Yes No No No Yes No Longitudinal
Prospective
11
Owman H; Arthritis &
Rheumatism; 2008;
18512778203
15 9 7 50(Range:
35e70)
No Yes No Yes No No No No No Longitudinal
Prospective
10
Madan-Sharma R;
Skeletal Radiology;
2008; 1856681375
186 74 112 60.2(Range:
43e76)
150 No No Yes Yes No No Yes Yes No Longitudinal
Prospective
11
Amin S; Journal of
Rheumatology;
2008; 18597397168
192 192 69(9) No No Yes Yes No No No No No Cross-sectional 10
Pelletier JP;
Osteoarthritis &
Cartilage; 2008;
1867238625
27 1 64.1(9.6) 14 No No Yes Yes Yes Yes Yes Yes No Other 9
Amin S; Arthritis
& Rheumatism;
2009; 19116936204
265 265 0 67(9) No No Yes Yes No No No No No Longitudinal
Prospective
16
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increase in grade of osteophyte, an increase in bone area was
seen of 146 mm2 in the medial compartment and 102 mm2 in
the lateral compartment38.
 Statistically signiﬁcant correlations were observed between
the medial tibial spur classiﬁcation on X-ray, the medial
meniscal displacement rate on MRI and the medial meniscal
signal change classiﬁcation on MRI39.
 Meniscal damage was mostly present in knees with OA and
demonstrates a relation to KLG40.
 Bone attrition of the tibiofemoral joint, scored>1, was found in
228 MRIs (23.6%) and in 55 radiographs (5.7%). Moderate to
strong correlation between MRIs and radiographs for bone
attrition of the tibiofemoral joint (r¼ 0.50, P< 0.001)41.
 Surface curvature of articular cartilage for both the ﬁne- and
coarse-scale estimates were signiﬁcantly higher in the OA
population compared with the healthy population, with
P< 0.001 and P< 0.001, respectively42.
 The prevalence of meniscal damage was signiﬁcantly higher
among subjects with radiographic evidence of tibiofemoral
osteoarthritis (KLG 2 or higher) than among thosewithout such
evidence (82% vs 25%, P< 0.001), and the prevalence increased
with a higher KLG (P< 0.001 for trend). Among persons with
radiographic evidence of severe osteoarthritis (KLG 3 or 4 in
their right knee), 95% had meniscal damage26.
Relation to radiographic joint space width
Nine studies examined the concurrent relation of MRI ﬁndings
in OA to radiographic joint space. Of these, 100% demonstrated
a statistically signiﬁcant association, deﬁned as P< 0.05.
 Strong correlation between the degree of medial meniscal
subluxation and the severity of medial joint space narrowing
(JSN) (r¼ 0.56, P¼ 0.0001)43.
 Meniscal extrusion identiﬁed in all 32 patients with JSN (KLG
1e4). Deﬁnite thinning or loss of articular cartilage was iden-
tiﬁed in only 15 of the 32 cases. In 17 patients with radiographic
JSN (KLG 1e3) and meniscal extrusion, no loss of articular
cartilage was observed. A statistically signiﬁcant correlation
(P< 0.001) was observed between KLG and degree of meniscal
extrusion and cartilage thinning on MRI44.
 For each increase in grade of JSN, tibial plateau bone area
increased by 160 mm2 in the medial compartment and
131 mm2 in the lateral compartment (signiﬁcance of regression
coefﬁcients all P< 0.001)38.
 Persons with symptomatic knee OAwith ACL rupture hadmore
severe radiologic OA (P< 0.0001) and were more likely to have
medial JSN (P< 0.0001) than a control sample45.
 Compartments of the knee joint without JSN had a higher
dGEMRIC index than those with any level of narrowing (mean
408 msec vs 365 msec; P¼ 0.001). In knees with 1 unnarrowed
(spared) and 1 narrowed (diseased) compartment, the dGEM-
RIC index was greater in the spared vs the diseased compart-
ment (mean 395 msec vs 369 msec; P¼ 0.001)32.
 Grade of JSN as measured on skyline and lateral patellofemoral
radiographs was inversely associated with patella cartilage
volume. After adjusting for age, gender and body mass index,
for every increase in grade of skyline JSN (0e3), the patella
cartilage volume was reduced by 411 mm3. For every increasein lateral patellofemoral JSN grade (0e3), the adjusted patella
cartilage volume was reduced by 125 mm3. The relationship
was stronger for patella cartilage volume and skyline JSN
(r¼0.54, P< 0.001) than for lateral patellofemoral JSN
(r¼0.16, P¼ 0.015)46.
 Grade one medial JSN was associated with substantial reduc-
tions in cartilage volume at both the medial and lateral tibial
and patellar sites within the knee (adjusted mean difference
11e13%, all P< 0.001)47.
 Cartilage volume in the medial compartment and the nar-
rowest JSW obtained by radiography at baseline in 31 knee OA
patients, revealed that some level of correlation exists between
these two measurements (r¼ 0.46, P< 0.007)48.
 Knee cartilage defects are inconsistently associated with JSN
after adjustment for osteophytes but consistently with knee
cartilage volume (beta: 0.27 to 0.70/ml; OR: 0.16e0.56/ml,
all P< 0.01 except for OR at lateral tibial cartilage site
P¼ 0.06)49.
 Moderate, but statistically signiﬁcant, correlation between JSW
and femoral and tibial cartilage volumes in the medial tibio-
femoral joint, which was strengthened by adjusting for medial
tibial bone size (R¼ 0.58e0.66, P¼ 0.001)50.
 JSN seen on both medial and lateral radiographs of the tibio-
femoral joint was inversely associatedwith the respective tibial
cartilage volume. This inverse relationship was strengthened
with adjustment for age, sex, body mass index (BMI), and bone
size. After adjustment for these confounders, for every increase
in JSN grade (0e3), the medial tibial cartilage volume was
reduced by 257 mm3 (95% CI 193e321) and the lateral tibial
cartilage volume by 396 mm3 (95% CI 283e509). The rela-
tionship between mean cartilage volume and radiologic grade
of JSN was linear28.Relation to alignment
10 studies examined the concurrent relation of MRI ﬁndings in
OA to alignment. Of these, 90% demonstrated a statistically signif-
icant association, deﬁned as P< 0.05.
 Valgus-aligned knees tended to have lower dGEMRIC values
laterally, and varus-aligned knees tended to have lower
dGEMRIC values medially; as a continuous variable, alignment
correlated with the lateral: medial dGEMRIC ratio (Pearson’s
R¼ 0.43, P¼ 0.02)32.
 Limbs with varus alignment, especially if marked (7 degrees),
had a remarkably high prevalence of medial lesions compared
with limbs that were neutral or valgus (74.3% vs 16.4%;
P < 0.001 for relation between alignment and medial lesions).
Conversely, limbs that were neutral or valgus had a much
higher prevalence of lateral lesions than limbs that were in the
most varus group (29.5% vs 8.6%; P¼ 0.002 for alignment and
lateral lesions)51.
 Medial tibial and femoral cartilage volumes increased as the
angle decreased (i.e., was less varus). Similarly, in the lateral
compartment there was an inverse association at baseline
between tibial and femoral cartilage volumes and the
measured knee angle52.
 The main univariate determinants of varus alignment in
decreasing order of inﬂuence were medial bone attrition,
medial meniscal degeneration, medial meniscal subluxation,
and medial tibiofemoral cartilage loss. Multivariable analysis
revealed that medial bone attrition and medial tibiofemoral
cartilage loss explained more of the variance in varus mala-
lignment than other variables. The main univariate determi-
nants of valgus malalignment in decreasing order of inﬂuence
D.J. Hunter et al. / Osteoarthritis and Cartilage 19 (2011) 557e588578were lateral tibiofemoral cartilage loss, lateral osteophyte
score, and lateral meniscal degeneration53.
 Correlation between medial meniscal displacement rate on
MRI and the femorotibial angle (r¼ 0.398)39.
 Worsening in the status of each medial lesion cartilage
morphology, subarticular bone marrow lesions, meniscal tear,
meniscal subluxation, and bone attrition was associated with
greater varus malalignment54.
 For every one degree increase in a valgus direction, there was
an associated reduced risk of the presence of cartilage defects
in themedial compartment of subjects with knee OA (P¼ 0.02).
Moreover, for every one degree increase in a valgus direction,
there was an associated increased risk of the presence of lateral
cartilage defects in the OA group (P¼ 0.006)55.Relation to CT
Four studies examined the concurrent relation of MRI ﬁndings
in OA to CT. Of these, 100% demonstrated a statistically signiﬁcant
association, deﬁned as P< 0.05. MR frequently showed tri-
compartmental cartilage loss when radiography and CT showed
only bicompartmental involvement in the medial and patellofe-
moral compartments. In the lateral compartment, MR showed
a higher prevalence of cartilage loss (60%) than radiography (35%)
and CT (25%) did. In the medial compartment, CT and MR showed
osteophytes in 100% of the knees, whereas radiography showed
osteophytes in only 60%. Notably, radiography often failed to show
osteophytes in the posterior medial femoral condyle. On MR
images, meniscal degeneration or tears were found in all 20 knees
studied. Partial and complete tears of the anterior cruciate ligament
were found in three and seven patients, respectively. MR is more
sensitive than radiography and CT for assessing the extent and
severity of osteoarthritic changes and frequently shows tri-
compartmental disease in patients in whom radiography and CT
showonly bicompartmental involvement. MR imaging is unique for
evaluating meniscal and ligamentous disease related to
osteoarthritis36.
 Strong linear relationship (r¼ 0.998) between MRI imaging
and CT arthrography. The mean absolute volume deviation
between magnetic resonance imaging and computed tomog-
raphy arthrography was 3.3%56.Relation to histology/pathology
Five studies examined the concurrent relation of MRI ﬁndings in
OA to histology/pathology. Of these, 60% demonstrated a statisti-
cally signiﬁcant association, deﬁned as P< 0.05.Observed
measurements of MRI volume of articular cartilage correlated with
actual weight and volume displacement measurements with an
accuracy of 82%e99% and linear correlation coefﬁcients of 0.99
(P¼ 2.5e-15) and 0.99 (P¼ 4.4e-15)57.
 The signal behavior of hyaline articular cartilage does not
reﬂect the laminar histologic structure. Osteoarthrosis and
cartilage degeneration are visible on MR images as intra-
cartilaginous signal changes, superﬁcial erosions, diffuse
cartilage thinning, and cartilage ulceration58.
 Comparison of data on cartilage thickness measurements with
MRI with corresponding histological sections in the middle of
each sector revealed a very goodmagnetic resonance/anatomic
correlation (r¼ 0.88)59.
 Correlation between MRI Noyes grading scores and Mankin
grading scores of natural lesions was moderately high (r¼ 0.7)
and statistically signiﬁcant (P¼ 0.001)60.Relation to arthroscopy
Seven studies examined the concurrent relation of MRI ﬁndings
in OA to arthroscopy. Of these, 71% demonstrated a statistically
signiﬁcant association, deﬁned as P< 0.05.
 Moderate correlation between imaged cartilage scores and the
arthroscopy scores (Pearson correlation coefﬁcient¼ 0.40)37.
 Spearman rank linear correlation between arthroscopic and
MR cartilage grading was highly signiﬁcant (P< 0.002) for each
of the six articular regions evaluated. The MR and arthroscopic
grades were the same in 93 (68%) of 137 joint surfaces, they
were the same or differed by one grade in 123 surfaces (90%),
and they were the same or differed by one or two grades in 129
surfaces (94%)61.
 The overall sensitivity and speciﬁcity of MR in detecting
chondral abnormalities were 60.5% (158/261) and 93.7% (89/
95) respectively. MR imaging was more sensitive to the higher
grade lesions: 31.8% (34/107) in grade 1; 72.4% (71/98) in grade
2; 93.5% (43/46) in grade 3; and 100% (10/10) in grade 4. The
MR and arthroscopic grades were the same in 46.9% (167/356),
and differed by no more than 1 grade in 90.2% (321/356) and 2
grades in 99.2% (353/356). The correlation between arthro-
scopic and MR grading scores was highly signiﬁcant with
a correlation coefﬁcient of 0.705 (P< 0.0001)62.
 Statistically signiﬁcant correlation between the SFA-arthro-
scopic score and the SFA-MR score (r¼ 0.83) and between the
SFA-arthroscopic grade and the SFA-MR grade (weighted
kappa¼ 0.84). The deepest cartilage lesions graded with
arthroscopy and MR imaging showed correlation in the medial
femoral condyle (weighted kappa¼ 0.83) and in the medial
tibial plateau (weighted kappa¼ 0.84)63.
 Magnetic resonance imaging was in agreement with arthros-
copy in 81% showing more degeneration but less tears of
menisci than arthroscopy. Using a global system for grading the
total damage of the knee joint into none, mild, moderate, or
severe changes, agreement between arthroscopy and MRI was
found in 82%64.
Predictive validity (Table III)
The analysis included data from 61 manuscripts of which
1 pertains to the hip and the remainder to the knee. The mean
Downs criteria score for these manuscripts was 11.5 (range 6e17).
What follows below are important excerpts from this data per-
taining to different aspects of predictive validity. The data is further
summarized in Table IV to discretely identify the associations
examined and those where a signiﬁcant association was found.
Prediction of joint replacement
Three studies examined the predictive relation of MRI ﬁndings
to joint replacement. Of these, 100% demonstrated a statistically
signiﬁcant association, deﬁned as P< 0.05.
 One study investigated the relation of change in quantitative
cartilage volume to risk of knee replacement. For every 1%
increase in the rate of tibial cartilage loss there was a 20%
increase risk of undergoing a knee replacement at four years
(95% CI, 10%e30%). Those in the highest tertile of tibial cartilage
loss had 7.1 (1.4e36.5) higher odds of undergoing a knee
replacement than those in the lowest tertile. Change in bone
area also predicted risk of TKR OR 12 (95% CI 1e14)65.
 Higher total cartilage defect scores (8e15) were associated
with a 6.0-fold increased risk of joint replacement over 4 yr
comparedwith thosewith lower scores (2e7) (95% CI 1.6, 22.3),
independently of potential confounders66.
Table IV
Summary of Predictive Validity of MRI in OA
Outcome of interest Number of
studies examining
this outcome
Number of
studies ﬁnding
signiﬁcant
associations (P< .05)
Joint replacement 3 studies 3 of 3 (100%)
Change in symptoms 6 studies 5 of 6 (83%)
Radiographic progression 8 studies 5 of 8 (63%)
MRI progression 19 studies 16 of 19 (84%)
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marrow lesions (assessed semi-quantitatively) to need for TKR.
Subjects who had a bone marrow lesion were 8.95 times as
likely to progress rapidly to a TKA when compared to subjects
with no BME (P¼ 0.016). There was no relation of TKR with
meniscal tear or cartilage loss67.
Prediction of change in symptoms
Six studies examined the predictive relation of MRI ﬁndings to
change in symptoms. Of these, 83% demonstrated a statistically
signiﬁcant association, deﬁned as P< 0.05.
 Weak associations between worsening of symptoms of OA and
increased cartilage loss: pain [r(s)¼ 0.28, P¼ 0.002], stiffness
[r(s)¼ 0.17, P¼ 0.07], and deterioration in function [r(s)¼ 0.21,
P¼ 0.02]20.
 Small study did not ﬁnd a signiﬁcant relation between changes
in WOMAC scores with the amount of cartilage loss and the
change in BME (P> 0.05)68.
 Multivariate analyses of knee pain 1 year following arthroscopic
partial meniscectomy demonstrated that medial tibial cartilage
damage accounting for 13% of the variability in pain scores69.
 The BOKS study examined the relationship between longitu-
dinal ﬂuctuations in synovitis with change in pain and cartilage
in knee osteoarthritis. Change in summary synovitis score was
correlated with the change in pain (r¼ 0.21, P¼ 0.0003). An
increase of one unit in summary synovitis score resulted in
a 3.15-mm increase in VAS pain score (0e100 scale). Effusion
change was not associated with pain change. Of the three
locations for synovitis, changes in the infrapatellar fat padwere
most strongly related to pain change24.
 A nested case-control study examined if enlarging BMLs are
associatedwithnewkneepain. Casekneewasdeﬁnedasabsence
of knee pain at baseline but presence of knee pain both times at
follow-up. Controls were selected randomly from among knees
with absence of pain at baseline. Among case knees, 54 of 110
(49.1%) showed an increase in BML score within a compartment,
whereas only 59of 220 control knees (26.8%) showedan increase
(P< 0.001 by chi-square test). A BML score increase of at least 2
units was much more common in case knees than in control
knees (27.5% vs 8.6%; adjusted odds ratio 3.2, 95% CI 1.5e6.8)70.
 Increases in Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) pain and patient global scores
over time are associated with change in cartilage volume of the
medial tibial plateau and medial femoral condyle71.
 Weak association of cartilage volume loss with less knee pain.
Medial cartilage volume loss and simultaneous pain change at
24months (beta coefﬁcient0.45, P¼ 0.03) and SF-36 physical
components (beta coefﬁcient 0.22, P¼ 0.04)72.Prediction of radiographic progression
Eight studies examined the predictive relation ofMRI ﬁndings to
radiographic progression. Of these, 63% demonstrated a statistically
signiﬁcant association, deﬁned as P< 0.05. No signiﬁcant association between reduction in JSW and
cartilage volume (R< 0.13). Trend toward a signiﬁcant associ-
ation between change in medial tibiofemoral cartilage volume
and joint replacement at 4 years (OR¼ 9.0, P¼ 0.07) but not
change in medial tibiofemoral JSW (OR¼ 1.1, P¼ 0.92)50.
 No correlation between the cartilage volume loss changes
(either by using absolute or percentage values) and the JSW
changes at 24months (global cartilage volume, r¼ 0.11; medial
compartment cartilage volume, r¼ 0.19)72.
 Medial femorotibial JSN after 1 year, assessed by radiography,
was signiﬁcantly correlatedwith a loss of medial tibial cartilage
volume (r¼ 0.25, P¼ 0.046) and medial tibial cartilage thick-
ness (r¼ 0.28, P¼ 0.025), over the same period73.
 Higher baseline composite cartilage scores and increases in
composite cartilage scores during follow-up were moderately
correlated with greater joint space loss (r¼ 0.33, P¼ 0.0002
and r¼ 0.26, P¼ 0.01, respectively)74.
 Loss in JSW correlated with the loss of cartilage volume on the
central weight-bearing area of the condyles and the plateaus as
well as on the medial compartment71.
 Study examined the relation of MRI features at baseline with
radiographically determined JSN in the medial compartment of
the knee after 2 years in a group of patients with symptomatic
osteoarthritis. A signiﬁcant association was observed for
meniscal tears (RR 3.57; CI 1.08e10.0) and meniscal subluxa-
tion (RR 2.73; CI 1.20e5.41), between KL< 2 and meniscal
subluxation (RR 11.3; CI 2.49e29.49) and KL 2 and meniscus
tears (RR 8.91; CI 1.13e22.84) and radiographic JSN 2 years
later75.Prediction of MRI progression
Nineteen studies examined the predictive relation of MRI ﬁnd-
ings to MRI progression. Of these, 84% demonstrated a statistically
signiﬁcant association, deﬁned as P< 0.05.
 Patients who had sustained meniscal tears showed a higher
average rate of progression of cartilage loss (22%) than that
seen in those who had intact menisci (14.9%) (P 0.018).
Anterior cruciate ligament (ACL) tears had a borderline signif-
icant inﬂuence P 0.06) on the progression of cartilage
pathology. Lesions located in the central region of the medial
compartment were more likely to progress to more advanced
cartilage pathology (progression rate 28%; P 0.003) than
lesions in the anterior (19%; P 0.564) and posterior (17%;
P 0.957) regions or lesions located in the lateral compartment
(average progression rate 15%; P 0.707). Lesions located in
the anterior region of the lateral compartment showed less
progression of cartilage degradation (6%; P 0.001). No speciﬁc
grade of lesion identiﬁed at baseline had a predilection for
more rapid cartilage loss (P 0.93)76.
 There was a signiﬁcant correlation between the degree of loss
of tibial cartilage and the degree of loss of femoral cartilage, in
both tibiofemoral joints (r¼ 0.81, P< 0.001 at the medial
tibiofemoral joint; r¼ 0.71, P< 0.001 at the lateral tibiofemoral
joint)77.
 A highly signiﬁcant difference in global cartilage volume loss
was observed between severe medial meniscal tear and
absence of tear [mean (SD), 10.1 (2.1)% v 5.1 (2.4)%,
P¼ 0.002]. An even greater difference was found between the
medial meniscal changes and medial compartment cartilage
volume loss [14.3 (3.0)% in the presence of severe tear v 6.3
(2.7)% in the absence of tear; P< 0.0001]. Similarly, a major
difference was found between the presence of a medial
meniscal extrusion and loss of medial compartment cartilage
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with no extrusion; P< 0.001]78.
 Annual patellar cartilage loss was highest in those with defects
comparedwith no defects (5.5% vs 3.2%, P¼ 0.01). Tibial cartilage
loss was not associated with defects in the medial (4.6% vs 5.8%,
P¼ 0.42) or lateral (4.7% vs 6.5%, P¼ 0.21) tibial cartilages66.
 Baseline cartilage defect score was negatively associated with
the progression of cartilage defects in each compartment (all
P< 0.001)79.
 Baseline cartilage defect scores at the medial tibia, lateral tibia,
and patella had a dose-response association with the annual
rate of change in knee cartilage volume at the corresponding
site (beta¼1.3% to 1.2% per grade; P< 0.05 for all compar-
isons). In addition, an increase in knee cartilage defect score
(change of more than or equal to 1) was associated with higher
rates of knee cartilage volume loss at all sites (beta¼1.9% to
1.7% per year; P< 0.01 for all comparisons). Furthermore,
a decrease in the knee cartilage defect score (change of less
than or equal to 1) was associated with an increase in knee
cartilage volume at all sites (beta¼ 1.0%e2.7% per year;
P< 0.05 for all comparisons)80.
 Predictors of fast progression included the presence of severe
meniscal extrusion (P¼ 0.001), severe medial tear (P¼ 0.005),
medial and/or lateral bone edema (P¼ 0.03), high body mass
index (P< 0.05, fast vs slow), weight (P< 0.05, fast vs slow) and
age (P< 0.05 fast vs slow)72.
 In the medial tibiofemoral joint, each measure of meniscal
malposition was associated with an increased risk of cartilage
loss. There was also a strong association between meniscal
damage and cartilage loss81.
 A worsening in cartilage defect score was signiﬁcantly associ-
ated with tibiofemoral osteophytes (OR, 6.22 and 6.04 per
grade), tibial bone area (OR, 1.24 and 2.07 per square centi-
meter), and cartilage volume (OR, 2.91 and 1.71 per ml in the
medial tibiofemoral and patellar compartments)82.
 Knee compartments with a higher baseline BML score had
greater cartilage loss. An increase in BMLs was strongly asso-
ciated with further worsening of the cartilage score83.
 Despite cartilage loss occurring in over 50% of knees, synovitis
was not associated with cartilage loss in either tibiofemoral or
patellofemoral compartment24.
 Signiﬁcant correlations were seen between the loss of cartilage
volume and edema size change in the medial condyle (0.40,
P¼ 0.0001) and the medial tibial plateau (0.23, P¼ 0.03), and
the changes in cyst size in the medial condyle (0.29, P¼ 0.01).
Amultivariate analysis showed that the edema size changewas
strongly and independently associated with medial cartilage
volume loss (0.31, P¼ 0.0004)84.
 Medial meniscal tear was associated with 103 mm(2) greater
tibial plateau bone area within the medial (95% CI 6.2, 200.3;
P¼ 0.04) and a lateral meniscal tear with a 120 mm(2) greater
area within the lateral compartment (95% CI 45.5, 195.2;
P¼ 0.002)85.
 Adjusting for age, body mass index, gender and baseline
cartilage scores, complete ACL tear increased the risk for
cartilage loss at the medial tibiofemoral compartment (OR: 1.8,
95% CI: 1.1, 3.2). However, following adjustment for the pres-
ence of medial meniscal tears, no increased risk for cartilage
loss was further seen (OR: 1.1, 95% CI: 0.6, 1.8)86.
 Medial meniscal damage predicted medial tibial cartilage
volume loss and tibial and femoral denuded bone increase,
while varus malalignment predicted medial tibial cartilage
volume and thickness loss and tibial and femoral denuded
bone increase. Lateral meniscal damage predicted every lateral
outcome87. A positive correlationwas found between the global severity of
synovitis at baseline and the loss of cartilage volume at 60 days
(P< 0.03)25.Discussion
The performance of MRI as an outcome measure in OA has been
extensively studied providing strong support for both its concur-
rent and predictive validity.
As outlined in this review numerous studies have examined the
relation of MRI to related constructs such as symptom measures,
plain radiography, histology and arthroscopy. These studies
demonstrate the following:
1. Inconsistent relation of structural features to symptoms with
13 of 21 studies ﬁnding a signiﬁcant relation. Generally strong
relation of large bone marrow lesions, moderate relation of
synovitis and effusion and weak relation of cartilage volume/
thickness to presence of pain. No relation of meniscal tears to
presence of pain.
2. In general there was an inconsistent relation of cartilage
volume and thickness and compositional measures to presence
of radiographic OA. Higher frequency of meniscal tears, syno-
vitis, increased bone area, increased bone attrition/curvature in
persons with radiographic OA. Radiographic change insensitive
to early changes found on MRI. 39 of 43 studies found signiﬁ-
cant associations between MRI and radiographic features.
3. There was a strong relation of meniscal subluxation and
increased subchondral bone area to reduced radiographic joint
space. Inconsistent (but generally moderate) relation of
reduced cartilage volume and thickness to reduced radio-
graphic joint space. Nine of nine studies found signiﬁcant
associations between MRI and radiographic joint space.
4. In general there was a strong correlation of cartilage volume
measures to histologic ﬁndings. Three of ﬁve studies found
signiﬁcant relation of MRI to histology/pathology.
5. Moderate to strong relation of arthroscopic ﬁndings to cartilage
andmeniscal ﬁndings onMRI with ﬁve of seven studies ﬁnding
a signiﬁcant association
6. Strong relation of CT arthrography to MRI cartilage volume
with all four studies examining this relation ﬁnding a signiﬁ-
cant association.
An important obstacle to biomarker validation and qualiﬁcation
is the adequate delineation of a gold standard. Unlike other diseases
where surrogate endpoints exist, OA does not have a clear gold
standard clinical endpoint and further is a remarkably heteroge-
neous disease. Therefore, the ‘clinical endpoint’ is more difﬁcult to
establish. A number of experts in the ﬁeld have advocated that joint
replacement be the clinical outcome of interest but due to
constraints over comorbidities, insurance status and a number of
other factors that inﬂuence determining if a person receives a joint
replacement, alternate suggestions have been recommended
including the use of virtual TKR (vTKR)88. This is a composite
endpoint that includes domains of pain, physical function and joint
structure on X-rays89. At this point it remains to be validated and as
a consequence the constituent literature in this review does not
include this endpoint to establish the predictive validity of MRI.
This workmay be susceptible to publication bias as therewas no
effort made to search either clinical trial registries or meeting
abstracts for potential unpublished studies that might tend to
invalidate the MRI biomarkers examined.
The literature on the predictive validity of MRI in OA demon-
strated the following:
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defects or bone marrow lesions are potential predictors of TKR.
Three of three studies found a signiﬁcant relation.
2. Inconsistent but generally weak relation of cartilage loss to
symptom change. Moderate relation of BML change to incident
symptoms and pain change. Weak relation of change in syno-
vitis to change in pain. Five of six studies found signiﬁcant
association between MRI and change in symptoms.
3. At best a weak relation between change in cartilage thickness
and change in joint space. Five of eight studies found a signiﬁ-
cant relation.
4. Presence of meniscal damage, cartilage defects and BMLs
predicts MRI progression. 16 of 19 studies found a signiﬁcant
relation.
Some MRI biomarkers correlate with some other biomarkers.
Moreover in a limited number of studies some MRI biomarkers
correlate with clinical endpoints and/or predict clinical outcomes
Future research should be directed toward improving the predic-
tive validity of current structural measures as they relate to
important clinical outcomes so their role as surrogate outcomes can
be substantiated. In addition, studies to improve the precision of
assessment of structural features more closely related to symptom
change such as BMLs and synovitis are warranted.Role of funding source
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